Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity

被引:411
作者
Newman, ENC
Holmes, RK
Craig, HM
Klein, KC
Lingappa, JR
Malim, MH
Sheehy, AM [1 ]
机构
[1] Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Infect Dis, London SE1 9RT, England
[2] Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA
基金
英国医学研究理事会;
关键词
D O I
10.1016/j.cub.2004.12.068
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The antiretroviral activity of the cellular enzyme APOBEC3G [1] has been attributed to the excessive deamination of cytidine (C) to uridine (U) in minus strand reverse transcripts, a process resulting in guanosine (G) to adenosine (A) hypermutation of plus strand DNAs [2-5]. The HIV-1 Vif protein counteracts APOBEC3G by inducing proteasomal degradation and exclusion from virions through recruitment of a cullin5 ECS E3 ubiquitin ligase complex [6-13]. APOBEC3G belongs to the APOBEC protein family, members of which possess consensus (H/C)-(A/V)-E-(X)24-30-P-C-(X)2-C cytidine deaminase motifs [14]. Earlier analyses of APOBEC-1 have defined specific residues that are important for zinc coordination, proton transfer, and, therefore, catalysis within this motif [15]. Because APOBEC3G contains two such motifs, we used site-directed mutagenesis of conserved residues to assess each region's contribution to anti-HIV-1 activity. Surprisingly, whereas either the N- or C-terminal domain could confer antiviral function in tissue culture-based infectivity assays, only an intact C-terminal motif was essential for DNA mutator activity. These findings reveal the nonequivalency of APOBEC3G's N- and C-terminal domains and imply that APOBEC3G-mediated DNA editing may not always be necessary for antiviral activity. Accordingly, we propose that APOBEC3G can achieve an anti-HIV-1 effect through an undescribed mechanism that is distinct from cytidine deamination.
引用
收藏
页码:166 / 170
页数:5
相关论文
共 30 条
[1]   CYTOSINE NUCLEOSIDE/NUCLEOTIDE DEAMINASES AND APOLIPOPROTEIN-B MESSENGER-RNA EDITING [J].
BHATTACHARYA, S ;
NAVARATNAM, N ;
MORRISON, JR ;
SCOTT, J ;
TAYLOR, WR .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (03) :105-106
[2]   Cytidine deamination of retroviral DNA by diverse APOBEC proteins [J].
Bishop, KN ;
Holmes, RK ;
Sheehy, AM ;
Davidson, NO ;
Cho, SJ ;
Malim, MH .
CURRENT BIOLOGY, 2004, 14 (15) :1392-1396
[3]   The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G [J].
Conticello, SG ;
Harris, RS ;
Neuberger, MS .
CURRENT BIOLOGY, 2003, 13 (22) :2009-2013
[4]   DNA determination mediates innate immunity to retroviral infection [J].
Harris, RS ;
Bishop, KN ;
Sheehy, AM ;
Craig, HM ;
Petersen-Mahrt, SK ;
Watt, IN ;
Neuberger, MS ;
Malim, MH .
CELL, 2003, 113 (06) :803-809
[5]   RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators [J].
Harris, RS ;
Petersen-Mahrt, SK ;
Neuberger, MS .
MOLECULAR CELL, 2002, 10 (05) :1247-1253
[6]   An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22 [J].
Jarmuz, A ;
Chester, A ;
Bayliss, J ;
Gisbourne, J ;
Dunham, I ;
Scott, J ;
Navaratnam, N .
GENOMICS, 2002, 79 (03) :285-296
[7]   The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity [J].
Kao, S ;
Khan, MA ;
Miyagi, E ;
Plishka, R ;
Buckler-White, A ;
Strebel, M .
JOURNAL OF VIROLOGY, 2003, 77 (21) :11398-11407
[8]   Hypermutation of HIV-1 DNA in the absence of the Vif protein [J].
Lecossier, D ;
Bouchonnet, F ;
Clavel, F ;
Hance, AJ .
SCIENCE, 2003, 300 (5622) :1112-1112
[9]   APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo [J].
Liddament, MT ;
Brown, WL ;
Schumacher, AJ ;
Harris, RS .
CURRENT BIOLOGY, 2004, 14 (15) :1385-1391
[10]   Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging [J].
Luo, K ;
Liu, BD ;
Xiao, ZX ;
Yu, YK ;
Yu, XH ;
Gorelick, R ;
Yu, XF .
JOURNAL OF VIROLOGY, 2004, 78 (21) :11841-11852